Viome Life Sciences Stock
HealthTechLooking to sell Viome Life Sciences stock or options?
Viome Life Sciences is a biotechnology and healthcare company focused on preventing and reversing chronic diseases. They digitize the human body and its microbiomes at a molecular level using at-home clinical-grade tests. These tests are analyzed through proprietary RNA sequencing technology, allowing them to decode precise health insights and biomarkers for various chronic diseases with the help of artificial intelligence and systems biology expertise. This enables healthcare providers to offer personalized nutrition recommendations and precision supplements to their patients.
Khosla Ventures, Bold Capital Partners, Eastward Capital Partners, Nomad Capital Partners, Veronorte, WestRiver Group, Hambrecht Ducera Growth Ventures, Better Health Group (Tampa), SquareOne Capital, Bulletproof Media, Minerva Capital Group, BlueTech, Ocgrow Ventures, Peter Diamandis, Gershon Capital, W.R. Hambrecht + Co., Marc Benioff, CerraCap Ventures, Grupo Nutresa, Ezaki Glico Company.